Registered number
04878702
Pura Pharmaceuticals Ltd
Filleted Accounts
31 March 2024
Pura Pharmaceuticals Ltd
Registered number: 04878702
Balance Sheet
as at 31 March 2024
Notes 2024 2023
£ £
Fixed assets
Intangible assets 3 - 10,500
Tangible assets 4 17,127 21,409
17,127 31,909
Current assets
Stocks 42,000 96,311
Debtors 5 101,832 31,918
Cash at bank and in hand 14,713 65,696
158,545 193,925
Creditors: amounts falling due within one year 6 (80,855) (90,062)
Net current assets 77,690 103,863
Total assets less current liabilities 94,817 135,772
Creditors: amounts falling due after more than one year 7 (12,894) (33,030)
Net assets 81,923 102,742
Capital and reserves
Called up share capital 100 100
Profit and loss account 81,823 102,642
Shareholders' funds 81,923 102,742
The directors are satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006.
The members have not required the company to obtain an audit in accordance with section 476 of the Act.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.
Mr Mohammad Ashkan-Nejad
Director
Approved by the board on 23 August 2024
Pura Pharmaceuticals Ltd
Notes to the Accounts
for the year ended 31 March 2024
1 Accounting policies
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract.
Intangible fixed assets
Intangible fixed assets are measured at cost less accumulative amortisation and any accumulative impairment losses.
Tangible fixed assets
Tangible fixed assets are measured at cost less accumulative depreciation and any accumulative impairment losses. Depreciation is provided on all tangible fixed assets, other than freehold land, at rates calculated to write off the cost, less estimated residual value, of each asset evenly over its expected useful life, as follows:
Plant and machinery 20%
Stocks
Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first in first out method. The carrying amount of stock sold is recognised as an expense in the period in which the related revenue is recognised.
Debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
Taxation
A current tax liability is recognised for the tax payable on the taxable profit of the current and past periods. A current tax asset is recognised in respect of a tax loss that can be carried back to recover tax paid in a previous period. Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Provisions
Provisions (ie liabilities of uncertain timing or amount) are recognised when there is an obligation at the reporting date as a result of a past event, it is probable that economic benefit will be transferred to settle the obligation and the amount of the obligation can be estimated reliably.
Pensions
Contributions to defined contribution plans are expensed in the period to which they relate.
2 Employees 2024 2023
Number Number
Average number of persons employed by the company 5 3
3 Intangible fixed assets £
Goodwill:
Cost
At 1 April 2023 105,000
At 31 March 2024 105,000
Amortisation
At 1 April 2023 94,500
Provided during the year 10,500
At 31 March 2024 105,000
Net book value
At 31 March 2024 -
At 31 March 2023 10,500
Goodwill is being written off in equal annual instalments over its estimated economic life of 10 years.
4 Tangible fixed assets
Plant and machinery etc
£
Cost
At 1 April 2023 52,013
At 31 March 2024 52,013
Depreciation
At 1 April 2023 30,604
Charge for the year 4,282
At 31 March 2024 34,886
Net book value
At 31 March 2024 17,127
At 31 March 2023 21,409
5 Debtors 2024 2023
£ £
Trade debtors 37,728 23,882
Directors current account 52,943 -
Paye debtors - 2,841
Card control 545 -
Other debtors 10,616 5,195
101,832 31,918
6 Creditors: amounts falling due within one year 2024 2023
£ £
Bank loans and overdrafts 10,440 12,047
Trade creditors 51,472 53,792
Taxation and social security costs 6,408 3,914
Netwages 9,589 4,709
Pensions liability 146 -
Directors current account - 15,600
Accruals 2,800 -
80,855 90,062
7 Creditors: amounts falling due after one year 2024 2023
£ £
Bank loans 12,894 33,030
8 Other information
Pura Pharmaceuticals Ltd is a private company limited by shares and incorporated in England. Its registered office is:
41 Stroud Green Road
London
N4 3EF
Pura Pharmaceuticals Ltd 04878702 false 2023-04-01 2024-03-31 2024-03-31 VT Final Accounts April 2024 Mr Mohammad Ashkan-Nejad No description of principal activity 04878702 2022-04-01 2023-03-31 04878702 core:WithinOneYear 2023-03-31 04878702 core:AfterOneYear 2023-03-31 04878702 core:ShareCapital 2023-03-31 04878702 core:RetainedEarningsAccumulatedLosses 2023-03-31 04878702 2023-04-01 2024-03-31 04878702 bus:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 04878702 bus:AuditExempt-NoAccountantsReport 2023-04-01 2024-03-31 04878702 bus:Director40 2023-04-01 2024-03-31 04878702 1 2023-04-01 2024-03-31 04878702 2 2023-04-01 2024-03-31 04878702 core:Goodwill 2023-04-01 2024-03-31 04878702 core:PlantMachinery 2023-04-01 2024-03-31 04878702 countries:England 2023-04-01 2024-03-31 04878702 bus:FRS102 2023-04-01 2024-03-31 04878702 bus:FilletedAccounts 2023-04-01 2024-03-31 04878702 2024-03-31 04878702 core:WithinOneYear 2024-03-31 04878702 core:AfterOneYear 2024-03-31 04878702 core:ShareCapital 2024-03-31 04878702 core:RetainedEarningsAccumulatedLosses 2024-03-31 04878702 core:Goodwill 2024-03-31 04878702 core:PlantMachinery 2024-03-31 04878702 2023-03-31 04878702 core:Goodwill 2023-03-31 04878702 core:PlantMachinery 2023-03-31 iso4217:GBP xbrli:pure